Telus Peptides

TB-500 + BPC-157 (separate vials)

Stack · 2 separate vials

Also known as BPC-157 and TB-500 stack

For reference only — not medical advice. Figures are commonly reported values compiled from published sources and may be wrong or out of date. Many compounds listed are not approved for human use. Talk to a licensed clinician before using any compound.

TB-500 and BPC-157 reconstituted in their own vials and used together, a pairing often reported in recovery-focused research protocols.

Rather than buying a premixed blend, some protocols keep TB-500 and BPC-157 in separate vials. Each vial is reconstituted on its own, so the two doses can be adjusted independently. The amounts below are drawn from each vial at its own concentration.

Commonly reported doses per vial

PeptideVial + waterDoseVolumeU-100 units
TB-5005 mg + 3 mL500 mcg0.3 mL30
BPC-1575 mg + 3 mL250 mcg0.15 mL15

Each vial is reconstituted on its own with the volume shown; volumes and units are per vial, not combined.

Frequency: Daily, subcutaneous

Notes

Sources

Last reviewed 2026-10-05.

In this stack

TB-500

Thymosin beta-4 fragment

TB-500 is a synthetic version of a region of the naturally occurring protein thymosin beta-4.

5 mg vial · Once daily, subcutaneous (a weekly loading pattern is also reported)

BPC-157

Synthetic pentadecapeptide

BPC-157 is a synthetic peptide derived from a sequence found in gastric juice.

5 mg vial · Once daily, subcutaneous (some reports split it into two injections)